TruNorth Capital Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-163
Closed -$7.69K – 338
2025
Q3
$7.69K Buy
+163
New +$7.87K ﹤0.01% 348
2025
Q2
– Sell
-1,378
Closed -$76.4K – 424
2025
Q1
$76.4K Buy
+1,378
New +$74.6K 0.02% 166

Other funds holding SNY

TruNorth Capital Management's SNY Position: Q4 2025 in Review

TruNorth Capital Management sold out of Sanofi (SNY) in Q4 2025, closing a stake of 163 shares — an estimated $7.69K sold.

TruNorth Capital Management first reported a position in SNY in Q1 2025 and held it in 2 quarters. The position peaked at $76.4K in Q1 2025. 758 funds tracked by Wall St. Rank hold SNY as of Q4 2025.

  • TruNorth Capital Management reported no remaining Sanofi position as of Q4 2025 after selling out during the quarter.
  • TruNorth Capital Management sold 163 Sanofi shares in Q4 2025, an estimated $7.69K.
  • TruNorth Capital Management first reported a position in Sanofi in Q1 2025 and held it in 2 quarters.
  • TruNorth Capital Management's Sanofi position peaked at $76.4K in Q1 2025.
  • 758 funds tracked by Wall St. Rank held Sanofi as of Q4 2025.

Based on TruNorth Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.